Coronary Artery Disease. We see you. Artrya expands U.S. commercial momentum with five-year HonorHealth agreement Five-year agreement with major Arizona health system demonstrates growing U.S. demand and ® broadens Salix customer acquisition PERTH, Australia, 13 November 2026: Artrya Limited (ASX:...
Five Yr Agreement with HonorHealth Expands US Momentum
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Artrya Limited has announced a five-year commercial agreement with HonorHealth, a major health system in Arizona, to expand its U.S. operations. This agreement marks HonorHealth as Artrya's fifth U.S. customer and the first secured outside its initial foundation customers. The contract includes a minimum value and potential for additional revenue through usage-based fees for assessments using Artrya's Salix platform. The partnership aims to enhance clinical workflows and develop a cardiovascular imaging Centre of Excellence in Arizona.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Earlier from Artrya
- Ceasing to be a substantial holder
- Becoming a substantial holder
- Artrya 2026 Annual General Meeting - Webinar Details
- September Quarterly Activities Report and Appendix 4C
- Artrya September Quarter - Report Timing & Investor Webinar
Later from Artrya
- AGM Chairmans Address and CEO Presentation
- Results of Annual General Meeting
- Issue of Shares on Exercise of Options & Cleansing Notice
- Application for quotation of securities - AYA
Follow Artrya into a list and get an email when it puts out news.
Follow Artrya